Medicus Pharma Ltd. -29MDCXWPreferred / convertible
13F holders, Q4 2024 (December 31)6holders
$1.16avg. 13F price*
At the end of Q4 2024, 6 institutions reported holding Medicus Pharma Ltd. -29 (MDCXW) in their 13F filings. The largest holders were Anson Funds Management LP ($103K), Clear Street LLC ($36K) and Hudson Bay Capital Management LP ($27K).
- Company
- Medicus Pharma Ltd. -29
- CUSIP
- 58471K111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $187K |
| Exits | 0 | $0 |
Ownership 6 holders
| Anson Funds Management LP | — | New | 42,400 | $103K |
| Clear Street LLC | — | New | 41,270 | $36K |
| Hudson Bay Capital Management LP | — | New | 41,300 | $27K |
| Warberg Asset Management LLC | — | New | 27,470 | $18K |
| Connective Capital Management, LLC | — | New | 6,000 | $2K |
| UBS Group AG | — | New | 2,000 | $702 |
"% of holder's portfolio" is MDCXW's weight in each manager's 13F, not the share of Medicus Pharma Ltd. -29 the manager owns.